$TNYA
Tenaya Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Tenaya Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is TNYA down today? It is at $0.350 (-5.30%), and our scanner flagged it 137 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TNYA spikes, and full due diligence on TNYA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TNYA 137 times in the last 30 days. Create a free account to track $TNYA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
TNYA is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on TNYA today, peaking at 41.0x its normal volume. Fresh from the SEC: Tenaya Therapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystTenaya Therapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Tingley Whittemore Officer | Acquired (grant/award) | +49K 0.02% of company | added 23% | 263K | n/a | Sep 10, 26 |
Ali Faraz Officer | Acquired (grant/award) | +122K 0.05% of company | added 29% | 540K | n/a | Sep 10, 26 |
Tingley Whittemore Officer | Sold (automatic/other) | -7K | sold 3.4% | 214K | $5K at $0.710 | Aug 17, 26 |
Ali Faraz Officer | Sold (automatic/other) | -22K | sold 5.1% | 418K | $16K at $0.710 | Aug 17, 26 |
Higa Tomohiro Officer | Sold (automatic/other) | -1K | sold 1.2% | 118K | $1K at $0.790 | May 18, 26 |
Tingley Whittemore Officer | Sold (automatic/other) | -3K | sold 1.4% | 215K | $2K at $0.790 | May 18, 26 |
Ali Faraz Officer | Sold (automatic/other) | -3K | sold 0.8% | 440K | $3K at $0.790 | May 18, 26 |
Column Group Iii Gp, Lp Beneficial Owner (10%) | Sold (automatic/other) | -3.51M 1.6% of company | sold 6.6% | 49.31M | $2.0M at $0.560 | Feb 25, 26 |
Column Group Iii Gp, Lp Beneficial Owner (10%) | Sold (automatic/other) | -658K 0.3% of company | sold 29% | 1.65M | $408K at $0.620 | Feb 24, 26 |
Column Group Iii Gp, Lp Beneficial Owner (10%) | Sold (automatic/other) | -306K 0.1% of company | sold 0.6% | 53.48M | $184K at $0.600 | Feb 23, 26 |
Column Group Iii Gp, Lp Beneficial Owner (10%) | Sold (automatic/other) | -524K 0.2% of company | sold 20% | 2.10M | $319K at $0.610 | Feb 20, 26 |
Tingley Whittemore Officer | Sold (automatic/other) | -5K | sold 2.3% | 219K | $3K at $0.640 | Feb 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
TNYA is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on TNYA today, peaking at 41.0x its normal volume. Fresh from the SEC: Tenaya Therapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026. A material company disclosure like this is often the real catalyst behind a move of this size.
TNYA last traded at $0.350, down 5.30% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Tenaya Therapeutics, Inc. Common Stock (TNYA) is next expected to report earnings on Monday, November 9, 2026, about 4 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TNYA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TNYA 137 times in the last 30 days.
TNYA (Tenaya Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $83M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TNYA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TNYA discussion
Sign in to ask a question or join the discussion.